Your Health Plan:
Your Health Plan:
Not SelectedHYRIMOZ (adalimumab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Juvenile arthritis, Juvenile polyarthritis, Arthritis, Psoriatic, Ankylosing spondylitis, Crohn Disease, Ulcerative Colitis and Psoriasis. HYRIMOZ is a tumor necrosis factor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $5400-20700.
Patient Assistance Prorgams are found:
Other alternatives to HYRIMOZ may include:
